These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 14521492)

  • 1. Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studies.
    Stein DJ; Davidson J; Seedat S; Beebe K
    Expert Opin Pharmacother; 2003 Oct; 4(10):1829-38. PubMed ID: 14521492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.
    Tucker P; Zaninelli R; Yehuda R; Ruggiero L; Dillingham K; Pitts CD
    J Clin Psychiatry; 2001 Nov; 62(11):860-8. PubMed ID: 11775045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission rates in patients with anxiety disorders treated with paroxetine.
    Ballenger JC
    J Clin Psychiatry; 2004 Dec; 65(12):1696-707. PubMed ID: 15641876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.
    Marshall RD; Schneier FR; Fallon BA; Knight CB; Abbate LA; Goetz D; Campeas R; Liebowitz MR
    J Clin Psychopharmacol; 1998 Feb; 18(1):10-8. PubMed ID: 9472837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focus on paroxetine.
    Green B
    Curr Med Res Opin; 2003; 19(1):13-21. PubMed ID: 12661775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of paroxetine in post-traumatic stress disorder (PTSD): 52-week, non-comparative open-label study for clinical use experience.
    Kim Y; Asukai N; Konishi T; Kato H; Hirotsune H; Maeda M; Inoue H; Narita H; Iwasaki M
    Psychiatry Clin Neurosci; 2008 Dec; 62(6):646-52. PubMed ID: 19068000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
    Trivedi MH; Pigotti TA; Perera P; Dillingham KE; Carfagno ML; Pitts CD
    J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot randomized controlled trial with paroxetine for subthreshold PTSD in Operation Enduring Freedom/Operation Iraqi Freedom era veterans.
    Naylor JC; Dolber TR; Strauss JL; Kilts JD; Strauman TJ; Bradford DW; Szabo ST; Youssef NA; Connor KM; Davidson JR; Marx CE
    Psychiatry Res; 2013 Apr; 206(2-3):318-20. PubMed ID: 23276723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial.
    Schneier FR; Neria Y; Pavlicova M; Hembree E; Suh EJ; Amsel L; Marshall RD
    Am J Psychiatry; 2012 Jan; 169(1):80-8. PubMed ID: 21908494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy.
    Simon NM; Connor KM; Lang AJ; Rauch S; Krulewicz S; LeBeau RT; Davidson JR; Stein MB; Otto MW; Foa EB; Pollack MH
    J Clin Psychiatry; 2008 Mar; 69(3):400-5. PubMed ID: 18348595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological functioning in patients with posttraumatic stress disorder following short-term paroxetine treatment.
    Fani N; Kitayama N; Ashraf A; Reed L; Afzal N; Jawed F; Bremner JD
    Psychopharmacol Bull; 2009; 42(1):53-68. PubMed ID: 19204651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.
    Golden RN; Nemeroff CB; McSorley P; Pitts CD; Dubé EM
    J Clin Psychiatry; 2002 Jul; 63(7):577-84. PubMed ID: 12143913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased neural response to trauma scripts in posttraumatic stress disorder following paroxetine treatment: A pilot study.
    Fani N; Ashraf A; Afzal N; Jawed F; Kitayama N; Reed L; Bremner JD
    Neurosci Lett; 2011 Mar; 491(3):196-201. PubMed ID: 21256927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spotlight on paroxetine in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
    Pollack MH; Zaninelli R; Goddard A; McCafferty JP; Bellew KM; Burnham DB; Iyengar MK
    J Clin Psychiatry; 2001 May; 62(5):350-7. PubMed ID: 11411817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder.
    Wagner KD; Berard R; Stein MB; Wetherhold E; Carpenter DJ; Perera P; Gee M; Davy K; Machin A
    Arch Gen Psychiatry; 2004 Nov; 61(11):1153-62. PubMed ID: 15520363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission of generalized anxiety disorder: a review of the paroxetine clinical trials database.
    Rickels K; Rynn M; Iyengar M; Duff D
    J Clin Psychiatry; 2006 Jan; 67(1):41-7. PubMed ID: 16426087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ziprasidone Augmentation of SSRI Antidepressants in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Pilot Study of Augmentation Therapy.
    Hamner MB; Hernandez-Tejada MA; Zuschlag ZD; Agbor-Tabi D; Huber M; Wang Z
    J Clin Psychopharmacol; 2019; 39(2):153-157. PubMed ID: 30640209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of posttraumatic stress disorder: the impact of paroxetine.
    Davidson JR
    Psychopharmacol Bull; 2003; 37 Suppl 1():76-88. PubMed ID: 14566203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD).
    Hetrick SE; Purcell R; Garner B; Parslow R
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007316. PubMed ID: 20614457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.